The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Sun., Jan. 29, 6:09 PM

Slide #90. BioNTech SE InstaDeep Ltd.

Acquirer: BioNTech SE (NASDAQ:BNTX)
Acquiree: InstaDeep Ltd.
Details: BioNTech SE (Nasdaq: BNTX, "BioNTech") and InstaDeep Ltd. ("InstaDeep") today announced that they have entered into an agreement under which BioNTech will acquire InstaDeep, a leading global technology company in the field of artificial intelligence ("AI") and machine learning ("ML"). The transaction includes a total upfront consideration of approximately 362 million in cash and BioNTech shares to acquire 100% of the remaining InstaDeep shares, excluding the shares already owned by BioNTech. In addition, InstaDeep shareholders will be eligible to receive additional performance-based future milestone payments up to approximately 200 million. The transaction follows BioNTech's initial equity investment as part of InstaDeep's Series B financing round in January 2022.

BioNTech develops immunotherapies for cancer and other diseases. Co.'s immunotherapy product candidates span the following four drug classes: messenger ribonucleic acid (mRNA) therapeutics, in which it is utilizing mRNA to deliver genetic information to cells; cell therapies, in which it is developing a range of cell therapies, including chimeric antigen receptorT cells, neoantigen-based T cell therapies and T cell receptor therapies; antibodies, in which it is developing antibodies that are designed to target immune checkpoints that modulate the patient's immune response to cancer; and small molecule immunomodulators, which is for the treatment of solid tumors in clinical testing.

Open the BNTX Page at The Online Investor »

Company Name: 
BioNTech SE
Stock buyback: 
BNTX buyback
Number of ETFs Holding BNTX: 
Total Market Value Held by ETFs: 

Open the BNTX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree BNTX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.11 out of 4)
34th percentile
(ranked lower than approx. 66% of all stocks covered)

Analysts' Target Price:
BNTX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page |

Copyright © 1998 - 2023, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.